Confinement Catalysis Enables Macrocyclization at Up to 0.6 M: Selective Formation of Mono- and Dimeric Glycosidic Macrocycles
Journal of the American Chemical Society · 01.04.2026 · 148 (12) · 13473-13482
DOI: 10.1021/jacs.6c03730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 18.03.2026. Verfasst von Sudip Guria und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Basel, Mattenstrasse 22, 4058 Basel, Switzerland. Hauptthemen laut MEDLINE: Macrocyclic Compounds, Glycosides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Macrocyclic compounds are widespread in nature and frequently found among bioactive natural products. Their conformational preorganization allows them to effectively engage large binding surfaces, making them valuable in drug discovery, especially for modulating protein-protein interactions. Consequently, macrocyclization strategies have received significant attention; however, they still typically rely on high-dilution conditions (0.10-10 mM) to favor intramolecular ring closure over intermolecular oligomerization. Here, we report a solution to this long-standing challenge using a catalytic confined-space approach that operates efficiently even at the substrate solubility limit (600 mM), thereby eliminating the need for high-dilution conditions. The capsular catalyst enables the high-yielding formation of medium- and large-sized glycosidic macrocycles with excellent β-selectivity. Moreover, the method addresses a second persistent challenge in macrocyclization: the selective formation of macrocyclic dimers. Whereas such dimers are inaccessible under traditional high-dilution conditions, they are obtained in high yields when two substrates fit into the capsule's cavity, again at high substrate concentrations and with excellent β,β-selectivity. Control experiments establish the indispensability of the capsule as conventional conditions afford substantially lower yields and predominantly α-selectivity. The method's utility is further demonstrated in the selective synthesis of the dimeric core structure of glucolipsin A and cycloviracin B1. This work establishes confinement catalysis as a powerful tool to overcome key limitations in macrocyclization chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Basel, Mattenstrasse 22, 4058 Basel, Switzerland.
- Department of Biosystems Science and Engineering, ETH Zurich, Schanzenstrasse 44, 4056 Basel, Switzerland.
ORCID-Profile: Sudip Guria, Alessandro Prescimone, Konrad Tiefenbacher
Förderung
- Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung
Zitieren
APA
Guria, S., Bechter, J., Prescimone, A., & Tiefenbacher, K. (2026). Confinement Catalysis Enables Macrocyclization at Up to 0.6 M: Selective Formation of Mono- and Dimeric Glycosidic Macrocycles. Journal of the American Chemical Society, 148(12), 13473-13482. https://doi.org/10.1021/jacs.6c03730
Vancouver
Guria S, Bechter J, Prescimone A, Tiefenbacher K. Confinement Catalysis Enables Macrocyclization at Up to 0.6 M: Selective Formation of Mono- and Dimeric Glycosidic Macrocycles. Journal of the American Chemical Society. 2026;148(12):13473-13482. doi:10.1021/jacs.6c03730
BibTeX
@article{Guria2026,
author = {Guria, Sudip and Bechter, Julia and Prescimone, Alessandro and Tiefenbacher, Konrad},
title = {Confinement Catalysis Enables Macrocyclization at Up to 0.6 M: Selective Formation of Mono- and Dimeric Glycosidic Macrocycles},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {12},
pages = {13473--13482},
doi = {10.1021/jacs.6c03730}
}
EUVIMED